Chlorine in PDB 5i4z: Structure of Apo Omomyc
Protein crystallography data
The structure of Structure of Apo Omomyc, PDB code: 5i4z
was solved by
W.Koelmel,
L.A.Jung,
J.Kuper,
M.Eilers,
C.Kisker,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
49.35 /
1.95
|
Space group
|
P 41 2 2
|
Cell size a, b, c (Å), α, β, γ (°)
|
65.700,
65.700,
149.500,
90.00,
90.00,
90.00
|
R / Rfree (%)
|
17.3 /
19.4
|
Other elements in 5i4z:
The structure of Structure of Apo Omomyc also contains other interesting chemical elements:
Chlorine Binding Sites:
The binding sites of Chlorine atom in the Structure of Apo Omomyc
(pdb code 5i4z). This binding sites where shown within
5.0 Angstroms radius around Chlorine atom.
In total 3 binding sites of Chlorine where determined in the
Structure of Apo Omomyc, PDB code: 5i4z:
Jump to Chlorine binding site number:
1;
2;
3;
Chlorine binding site 1 out
of 3 in 5i4z
Go back to
Chlorine Binding Sites List in 5i4z
Chlorine binding site 1 out
of 3 in the Structure of Apo Omomyc
 Mono view
 Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 1 of Structure of Apo Omomyc within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl103
b:71.5
occ:1.00
|
H
|
A:LYS45
|
2.4
|
49.6
|
1.0
|
HG3
|
A:LYS45
|
3.0
|
53.2
|
1.0
|
HA
|
A:PRO44
|
3.2
|
45.6
|
1.0
|
N
|
A:LYS45
|
3.2
|
41.3
|
1.0
|
HB2
|
A:LYS45
|
3.3
|
50.2
|
1.0
|
CL
|
A:CL104
|
3.4
|
63.9
|
1.0
|
HB3
|
A:PRO44
|
3.4
|
55.6
|
1.0
|
HD2
|
A:LYS45
|
3.6
|
83.3
|
1.0
|
CG
|
A:LYS45
|
3.7
|
44.4
|
1.0
|
HE3
|
A:LYS45
|
3.7
|
0.1
|
1.0
|
CB
|
A:LYS45
|
3.8
|
41.8
|
1.0
|
CA
|
A:PRO44
|
3.9
|
38.0
|
1.0
|
CD
|
A:LYS45
|
4.0
|
69.4
|
1.0
|
C
|
A:PRO44
|
4.0
|
31.7
|
1.0
|
CB
|
A:PRO44
|
4.1
|
46.3
|
1.0
|
O2
|
A:GOL101
|
4.1
|
62.6
|
1.0
|
CA
|
A:LYS45
|
4.1
|
41.7
|
1.0
|
CE
|
A:LYS45
|
4.3
|
85.9
|
1.0
|
HG2
|
A:LYS45
|
4.5
|
53.2
|
1.0
|
H
|
A:VAL46
|
4.5
|
36.0
|
1.0
|
HB2
|
A:PRO44
|
4.6
|
55.6
|
1.0
|
HO2
|
A:GOL101
|
4.7
|
75.1
|
1.0
|
HB3
|
A:LYS45
|
4.7
|
50.2
|
1.0
|
HA
|
A:LYS45
|
4.7
|
50.0
|
1.0
|
H2
|
A:GOL101
|
4.9
|
95.3
|
1.0
|
HE2
|
A:LYS45
|
4.9
|
0.1
|
1.0
|
HD3
|
A:LYS45
|
4.9
|
83.3
|
1.0
|
|
Chlorine binding site 2 out
of 3 in 5i4z
Go back to
Chlorine Binding Sites List in 5i4z
Chlorine binding site 2 out
of 3 in the Structure of Apo Omomyc
 Mono view
 Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 2 of Structure of Apo Omomyc within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl104
b:63.9
occ:1.00
|
H
|
A:VAL46
|
2.2
|
36.0
|
1.0
|
HG23
|
A:VAL46
|
2.6
|
61.3
|
1.0
|
HB2
|
A:LYS45
|
3.0
|
50.2
|
1.0
|
HB
|
A:VAL46
|
3.0
|
47.3
|
1.0
|
N
|
A:VAL46
|
3.0
|
30.0
|
1.0
|
H
|
A:LYS45
|
3.1
|
49.6
|
1.0
|
HB3
|
A:PRO44
|
3.2
|
55.6
|
1.0
|
CG2
|
A:VAL46
|
3.4
|
51.1
|
1.0
|
CL
|
A:CL103
|
3.4
|
71.5
|
1.0
|
N
|
A:LYS45
|
3.4
|
41.3
|
1.0
|
CB
|
A:VAL46
|
3.5
|
39.4
|
1.0
|
HB2
|
A:PRO44
|
3.5
|
55.6
|
1.0
|
HG21
|
A:VAL46
|
3.6
|
61.3
|
1.0
|
CB
|
A:PRO44
|
3.8
|
46.3
|
1.0
|
CB
|
A:LYS45
|
3.8
|
41.8
|
1.0
|
CA
|
A:VAL46
|
3.8
|
36.1
|
1.0
|
CA
|
A:LYS45
|
3.9
|
41.7
|
1.0
|
C
|
A:LYS45
|
3.9
|
35.9
|
1.0
|
C
|
A:PRO44
|
4.0
|
31.7
|
1.0
|
HD13
|
B:LEU23
|
4.1
|
65.3
|
1.0
|
HG22
|
A:VAL46
|
4.2
|
61.3
|
1.0
|
H
|
A:VAL47
|
4.2
|
40.2
|
1.0
|
CA
|
A:PRO44
|
4.3
|
38.0
|
1.0
|
HB3
|
A:LYS45
|
4.3
|
50.2
|
1.0
|
HA
|
A:PRO44
|
4.4
|
45.6
|
1.0
|
HA
|
A:VAL46
|
4.5
|
43.3
|
1.0
|
HD2
|
A:LYS45
|
4.6
|
83.3
|
1.0
|
HG3
|
A:LYS45
|
4.7
|
53.2
|
1.0
|
O
|
A:PRO44
|
4.8
|
34.9
|
1.0
|
N
|
A:VAL47
|
4.8
|
33.5
|
1.0
|
CG
|
A:LYS45
|
4.8
|
44.4
|
1.0
|
HA
|
A:LYS45
|
4.8
|
50.0
|
1.0
|
C
|
A:VAL46
|
4.9
|
40.2
|
1.0
|
CG1
|
A:VAL46
|
4.9
|
37.7
|
1.0
|
CD1
|
B:LEU23
|
5.0
|
54.4
|
1.0
|
HD12
|
B:LEU23
|
5.0
|
65.3
|
1.0
|
|
Chlorine binding site 3 out
of 3 in 5i4z
Go back to
Chlorine Binding Sites List in 5i4z
Chlorine binding site 3 out
of 3 in the Structure of Apo Omomyc
 Mono view
 Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 3 of Structure of Apo Omomyc within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Cl102
b:66.4
occ:1.00
|
H
|
B:LYS45
|
2.2
|
36.8
|
1.0
|
HG3
|
B:LYS45
|
2.7
|
35.0
|
1.0
|
N
|
B:LYS45
|
3.1
|
30.7
|
1.0
|
HA
|
B:PRO44
|
3.2
|
43.7
|
1.0
|
HB2
|
B:LYS45
|
3.3
|
34.6
|
1.0
|
HB2
|
B:PRO44
|
3.3
|
45.0
|
1.0
|
O
|
B:HOH228
|
3.4
|
29.1
|
1.0
|
CG
|
B:LYS45
|
3.5
|
29.1
|
1.0
|
HB3
|
B:PRO44
|
3.5
|
45.0
|
1.0
|
HD2
|
B:LYS45
|
3.7
|
51.8
|
1.0
|
CB
|
B:PRO44
|
3.7
|
37.5
|
1.0
|
CA
|
B:PRO44
|
3.7
|
36.4
|
1.0
|
CB
|
B:LYS45
|
3.7
|
28.8
|
1.0
|
C
|
B:PRO44
|
3.9
|
31.3
|
1.0
|
HE3
|
B:LYS45
|
4.0
|
92.4
|
1.0
|
CA
|
B:LYS45
|
4.0
|
29.9
|
1.0
|
CD
|
B:LYS45
|
4.1
|
43.2
|
1.0
|
O
|
B:HOH235
|
4.1
|
52.4
|
1.0
|
HG2
|
B:LYS45
|
4.3
|
35.0
|
1.0
|
H
|
B:VAL46
|
4.5
|
29.8
|
1.0
|
CE
|
B:LYS45
|
4.6
|
77.0
|
1.0
|
HA
|
B:LYS45
|
4.6
|
35.8
|
1.0
|
HB3
|
B:LYS45
|
4.7
|
34.6
|
1.0
|
HH11
|
A:ARG20
|
4.7
|
88.8
|
1.0
|
HD3
|
B:LYS45
|
4.9
|
51.8
|
1.0
|
|
Reference:
L.A.Jung,
A.Gebhardt,
W.Koelmel,
C.P.Ade,
S.Walz,
J.Kuper,
B.Von Eyss,
S.Letschert,
C.Redel,
L.D'artista,
A.Biankin,
L.Zender,
M.Sauer,
E.Wolf,
G.Evan,
C.Kisker,
M.Eilers.
Omomyc Blunts Promoter Invasion By Oncogenic Myc to Inhibit Gene Expression Characteristic of Myc-Dependent Tumors. Oncogene V. 36 1911 2017.
ISSN: ESSN 1476-5594
PubMed: 27748763
DOI: 10.1038/ONC.2016.354
Page generated: Fri Jul 26 09:09:11 2024
|